CAT vs INM · P/E 48, rev $37.96B vs rev $4.9M
Caterpillar Inc (CAT) versus InMed Pharmaceuticals Inc (INM) — a side-by-side from cached financials, not a winner call.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE. It is led by Jim Umpleby.
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CAT revenue for 2026-06-30 was $37.96B. Net income was $6.14B. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. INM currently screens at market cap $5.2M.
CAT currently screens at market cap $440.29B and trailing P/E 47.7. INM currently screens at market cap $5.2M.
Not investment advice. Open the CAT and INM stock pages for the full models.
Not investment advice.